Click to view 3D structure | Cytochrome P450 2C19 | P33261 | Humans | Predicted (SEA) | 299.797 |
Click to view 3D structure | Cytochrome P450 3A4 | P08684 | Humans | Predicted (SEA) | 805.506 |
Click to view 3D structure | Cytochrome P450 2C9 | P11712 | Humans | Predicted (SEA) | 629.1 |
Click to view 3D structure | Cytochrome P450 1A2 | P05177 | Humans | Predicted (SEA) | 432.53 |
Click to view 3D structure | Cytochrome P450 2D6 | P10635 | Humans | Predicted (SEA) | 671.216 |
Click to view 3D structure | Cgd5_820 protein | F0X4H1 | Cryptosporidium parvum | Predicted (SEA) | 1.55698 |
Click to view 3D structure | Mitogen-activated protein kinase | A3FQ79 | Cryptosporidium parvum (strain Iowa II) | Predicted (SEA) | 1.55698 |
Click to view 3D structure | Calcium/calmodulin-dependent protein kinase with a kinase domain and 2 calmodulin-like EF hands | Q5CZ29 | Cryptosporidium parvum (strain Iowa II) | Predicted (SEA) | 1.55698 |
Click to view 3D structure | Calcium/calmodulin-dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | Q5CYL9 | Cryptosporidium parvum (strain Iowa II) | Predicted (SEA) | 1.55698 |
Click to view 3D structure | Cell division control protein 28, putative | A3FPL9 | Cryptosporidium parvum (strain Iowa II) | Predicted (SEA) | 1.55698 |
Click to view 3D structure | Calcium-dependent protein kinase 2 | Q6S4V9 | Cryptosporidium parvum | Predicted (SEA) | 1.55698 |
Click to view 3D structure | Vascular endothelial growth factor receptor 1 | P17948 | Humans | Predicted (SEA) | 799.979 |
Click to view 3D structure | Cytochrome P450 1B1 | Q16678 | Humans | Predicted (SEA) | 70.8428 |
Click to view 3D structure | Peptidyl-prolyl cis-trans isomerase A | P10111 | Rattus norvegicus | Predicted (SEA) | 32.0739 |
Click to view 3D structure | Membrane metallo-endopeptidase-like 1 | Q495T6 | Humans | Predicted (SEA) | 11.4438 |
Click to view 3D structure | Glycogen synthase kinase-3 beta | P49841 | Humans | Predicted (SEA) | 1302.81 |
Click to view 3D structure | Glycogen synthase kinase-3 alpha | P49840 | Humans | Predicted (SEA) | 961.749 |
Click to view 3D structure | 17-beta-hydroxysteroid dehydrogenase type 2 | P37059 | Humans | Predicted (SEA) | 35.7328 |
Click to view 3D structure | 17-beta-hydroxysteroid dehydrogenase type 1 | P14061 | Humans | Predicted (SEA) | 31.3732 |
Click to view 3D structure | Tubulin alpha 4a | C5ISA2 | Ovis aries | Predicted (SEA) | 15.2584 |
Click to view 3D structure | Cytochrome P450 2B6 | P20813 | Humans | Predicted (SEA) | 81.041 |
Click to view 3D structure | Cannabinoid receptor 1 | P21554 | Humans | Predicted (SEA) | 312.02 |
Click to view 3D structure | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Q13627 | Humans | Predicted (SEA) | 1540.95 |
Click to view 3D structure | Sodium-dependent serotonin transporter | P31645 | Humans | Predicted (SEA) | 787.678 |
Click to view 3D structure | 5-hydroxytryptamine receptor 3A | P46098 | Humans | Predicted (SEA) | 346.195 |
Click to view 3D structure | Estrogen receptor | P03372 | Humans | Known | Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590) |
Click to view 3D structure | Estrogen receptor beta | Q92731 | Humans | Known | Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590) |
Click to view 3D structure | Sulfotransferase 1E1 | P49888 | Humans | Known | PCBs can cause endocrine disurption by binding to estrogen sulfotransferase, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. (A3, A66) |
Click to view 3D structure | Aromatic-L-amino-acid decarboxylase | P20711 | Humans | Known | PCB inhibition of aromatic-L-amino-acid decarboxylase is believed to cause decreased dopamine synthesis. (L4) |
Click to view 3D structure | Aryl hydrocarbon receptor | P35869 | Humans | Known | Dioxin-like PCBs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic Phase I and Phase II enzymes, especially of the cytochrome P450 family. (A4) |
Click to view 3D structure | Tyrosine 3-monooxygenase | P07101 | Humans | Known | PCB inhibition of tyrosine 3-monooxygenase is believed to cause decreased dopamine synthesis. (L4) |
Click to view 3D structure | Uteroglobin | P11684 | Humans | Known | PCBs will bioaccumulate by binding to receptor proteins such as uteroglobin. (A30) |